nivolumab,ipilimumab
bms
['nivo', 'nsclc', 'nivolumab', 'sclc', 'increase,(-increased)', 'ipilimumab']
dr. idris bahce presents data from the increase trial - ipilimumab plus nivolumab and chemoradiation followed by surgery in resectable and borderline resectable nsclc. #esmo22 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him